Sub Logo

Li Ka Shing Institute of Virology

About Us

The Li Ka Shing Institute of Virology

The Li Ka Shing Institute of Virology was created in 2010 through the combined gifts of $25-million from the Li Ka Shing (Canada) Foundation and $52.5-million from the Government of Alberta and  incorporates researchers from the Alberta Institute for Viral Immunology and the Centre of Excellence for Viral Hepatitis Research.

The Centre of Excellence for Viral Hepatitis Research

This entity brings together clinicians and basic scientists to study the development of hepatitis vaccines and antiviral therapies, animal models and cell culture models, genetic based population studies, epidemiological studies of populations at risk, and programs to reduce fatal outcomes of viral hepatitis infection.

The Alberta Institute for Viral Immunology (AIVI)

The AIVI was created in 2008 through joint funding from the Alberta Government (Advanced Education and Technology) and the Canadian Foundation for Innovation (CFI). Our new building and core facilities are nearing completion. Contact information and travel directions to the university are available through the home pagemenu. More content will be added as the AIVI takes shape.  AIVI Proposal.  AIVI is an organization that links together Alberta-based virologists and immunologists.  It gained its initial impetus from a 2006 $24.9 million Canadian Foundation for Innovation (CFI) award and was granted formal institute status by the University of Alberta’s General Faculties Council in 2007.  AIVI Infrastructure is currently being designed and built at the University of Alberta and the University of Calgary. The University of Alberta is the lead for this project and in Edmonton the new facilities we are building include a BSL3-level animal biocontainment suite (available2011), new siRNA robotics, imaging, and other core facilities (operational), and a BSL-2 animal biocontainment suite (March 2011). These facilities will provide biosafe and biosecure laboratory space that will greatly facilitate research involving infectious agents.

 

Main Focus of the Li Ka Shing Institute of Virology:

  1. Prominently identify the philanthropy of the Li Ka Shing Foundation with one of the world’s leading centers for viral drug and vaccine testing and development
  2. Crystallise an identifiable home for virology researchers at the university of Alberta – Canada’s leading university for virology research
  3. Attract excellent trainees (graduate students and post-doctoral fellows) by providing intern support to provincially or nationally funded scholarship programs
  4. Leverage funding to support novel animal models
  5. Leverage funding for new platform technologies, e.g. siRNA screening for novel cellular targets for antiviral development
  6. Enhance recruitment of world leading researchers, e.g. influenza A
  7. Enhance national and international collaborations with an emphasis on building a global network of virology researchers and initiatives
  8. Maintain a translational focus

 

Research Highlights

The research interests of LKSIOV faculty members encompass viral pathogenesis,
vaccine development, correlates of immunity, enhancement of vaccine efficacy and
novel viral therapeutics with expertise in:
• Adenoviruses
• Influenza viruses
• Flaviviruses
• Pox viruses
• Hepatitis B and C viruses
• Rubella virus
• Herpesviruses
• West Nile Virus
• Dengue Virus